实验动物科学 ›› 2018, Vol. 35 ›› Issue (04): 40-.

• 研究报告 • 上一篇    下一篇

铜绿假单胞菌注射液对H22小鼠移植瘤的辅助治疗效果

  

  1. (1. 广东省医学实验动物中心,佛山 528248)(2. 北京万特尔生物制药有限公司,北京 100000)
  • 出版日期:2018-08-28 发布日期:2020-08-28

The Efficacy of Pseudomonas Aeruginosa-mannose Sensitive Hemagglutinin on H22 Mice Transplanted Tumor

  • Online:2018-08-28 Published:2020-08-28

摘要: 目的 研究铜绿假单胞菌注射液联合化疗对H22小鼠移植瘤的影响。方法 采用H22细胞株,移植53只BALB/c小鼠皮下。取肿块大小相对均匀的48只小鼠随机分成6组:空白对照、铜绿假单胞菌组、联合顺铂组、联合阿霉素组、顺铂组、阿霉素组,8只/组。连续给药14 d。结果 联合顺铂组、顺铂组的抑瘤率为49.2%、46.6%,联合阿霉素组、阿霉素组的抑瘤率为32.1%、19.8%。结论 铜绿假单胞菌注射液对H22小鼠移植瘤的阿霉素化疗有一定的增强效果。

关键词: 铜绿假单胞菌注射液, 联合化疗, H22

Abstract: Objective The efficacy of pseudomonas aeruginosa-mannose sensitive hemagglutinin on H22 mice transplanted tumor.Method H22 cells were implanted into the subcutaneously of 53 BALB/c mice. Forty eight mice were randomly divided into 6 groups. And set up Control group, Pseudomonas aeruginosa group, Combined cisplatin group, Combined adriamycin group, cisplatin group, adriamycin group, 8 mice/group. Continuous administration for 14 days. Result The tumor inhibition rate of combined cisplatin group and cisplatin group were 49.2% and 46.6%, and the tumor inhibition rate of adriamycin group and adriamycin group was about 32.1% and 19.8%.Conclusion Pseudomonas Aeruginosa Injection can enhance the effect of adriamycin chemotherapy on H22 mice.

Key words: Pseudomonas aeruginosa-mannose sensitive hemagglutinin, combined chemotherapy, H22